熱稀釋導管市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)
市場調查報告書
商品編碼
1273488

熱稀釋導管市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Thermodilution Catheter Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 111 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內,熱稀釋導管市場的複合年增長率預計為 5.5%。

由於選擇性手術(包括心血管疾病的診斷和治療)的取消,COVID-19 對所研究的市場產生了負面影響。 例如,根據美國國家醫學圖書館發表的一篇論文,到2022年3月,美國成人心臟手術數量將減少52.7%,擇期手術數量將減少65.5%。 中大西洋地區在早期階段受 COVID-19 激增的影響最大,總體病例下降 69.7%,選擇性病例下降 80.0%。 在 COVID-19 激增之後,全國心臟手術病例數並未恢復到基線水平,表明 COVID-19 相關心臟手術患者短缺。 因此,COVID-19 對心臟護理產生了重大影響,因此,熱稀釋導管市場也受到了影響。 然而,根據分析,由於 COVID-19 患者數量減少,當前市場正在穩步增長,預計未來幾年將呈現類似趨勢。

心髒病和中風發病率的上升,以及用於開發心肌梗塞管理新技術的研發活動的增加,對所研究市場的增長產生了積極影響。 例如,根據美國心臟協會 2022 年 1 月發布的“心髒病和中風統計更新情況說明書”,全球有 2.441 億人患有缺血性心髒病,其中男性多於女性(分別為 1.411 億和 1.031 億)。 此外,根據世界衛生組織2021年6月更新的數據,全球約有3350萬人患有心房顫動(AFib),這是嚴重心律失常的代表。 預計心髒病和中風的激增將推動治療這些疾病所需的熱稀釋導管的需求,最終推動市場增長。

主要市場參與者的產品批准、發布、合作夥伴關係和收購的增加預計將促進市場增長。 例如,2022 年 7 月,從瑞士蘇黎世聯邦理工學院 (ETH) 分拆出來的蘇黎世公司 Nanoflex Robotics 開發了一種創新導管,用於對中風患者進行快速手術干預。 預計此類市場發展將推動市場增長。

雖然市場呈上升趨勢,但新興市場缺乏熟練的醫療保健專業人員以及難以在患者心臟中定位導管可能會阻礙市場增長。有。

熱稀釋導管市場趨勢

預測期內聚氨酯熱稀釋導管有望增長

聚氨酯熱稀釋導管由於其應用範圍廣、安全、降低患者對乳膠過敏和超敏反應的風險、無刺激性等特點,近年來佔據了較大的市場份額,而且這一趨勢在預測期間仍將持續期間。預計將繼續。 聚氨酯導管也有望在預測期內引領該領域,因為與硅膠導管相比,聚氨酯導管具有更高的機械強度和柔韌性,因此越來越多地被醫生採用。 例如,根據 2022 年 7 月在 NCBI 上發表的一篇文章,將 Swan-Ganz 導管或右心導管連接到體外壓力傳感器,以確定中心靜脈壓、右心房壓、右心室壓和肺動脈壓. 帶稀釋傳感器的四腔導管。 這些好處,加上熱稀釋導管用於肺動脈壓力監測的迅速增加,可能會增加製造商的需求並推動全球市場。

此外,企業活動的增加和產品創新預計也將在預測期內推動市場增長。 例如,2022 年 3 月,CATHI 將推出一款新的右心導管模擬器,該模擬器提供 CATHI 原始 RHC 模擬器的所有功能,增加了線輔助導航和使用真實液體 (S-HUB) 的可能性,從而允許熱稀釋發生。

熱稀釋導管市場-IMG1

在預測期內,預計北美的熱稀釋導管市場將出現顯著增長。

北美的特點是心髒病發病率上升、人口老齡化、醫療保健基礎設施更好、公眾和醫療保健利益相關者對可用技術的認識,以及行業參與者在該地區的強大影響力。預計該市場將出現顯著增長,因為因素,例如: 例如,根據 CDC 的 2022 年更新,美國 1210 萬人可能在 2030 年出現心房顫動。 根據同一消息來源,美國每 34 秒就有一人死於心血管疾病。 到 2020 年,美國將有大約 697,000 人死於心髒病,即五分之一。 由於這種疾病的高負擔和嚴重性,我們預計熱稀釋導管在該地區的使用會增加。

該地區正在開展各種運動,以挽救受心髒病影響的生命。 例如,美國醫療保險和醫療補助服務中心和疾病預防控制中心正在聯合領導全國范圍的百萬愛心運動。 該活動將於 2022 年 1 月開始,並將持續到 2026 年 12 月。 該倡議的目標是在五年內預防一百萬例心髒病發作和中風。 我們相信,這樣的努力將加快心髒病的治療和診斷,以預防中風和其他心髒病,並最終增加熱稀釋導管用於監測心輸出量的使用。預計在預測期內加強該地區的市場.

熱稀釋導管市場-IMG2

熱稀釋導管行業概況

由於少數公司在全球和區域開展業務,因此熱稀釋導管市場本質上是整合的。 競爭格局包括對具有市場份額的幾家知名國際和地區公司的分析。 主要市場參與者包括 Alpha Medical Instruments LLC、Edwards Lifesciences、Teleflex Incorporated、DeRoyal Industries、ICU Medical Inc、Nolato AB、B. Braun SE、Merit Medical Systems Inc、Avicenna Healthcare Solutions、Advanced Lifesciences Pvt Ltd 等。

其他福利:

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 調查假設和市場定義
  • 本次調查的範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 心髒病的全球流行和中風發病率的增加
    • 啟動研發活動以開發心臟卒中管理新技術
  • 市場製約因素
    • 難以將導管置入患者心臟
    • 新興經濟體缺乏熟練的醫療保健專業人員
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分(基於價值的市場規模

  • 按材料
    • 聚氨酯
    • 尼龍
    • 其他材料
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Alpha Medical Instruments LLC
    • Teleflex Incorporated
    • Edwards Lifesciences
    • DeRoyal Industries
    • ICU Medical Inc
    • Nolato AB
    • B. Braun SE
    • Merit Medical Systems Inc
    • Advanced Lifesciences Pvt Ltd

第七章市場機會與未來趨勢

簡介目錄
Product Code: 67854

The thermodilution catheter market is expected to register a CAGR of 5.5% during the forecast period.

The impact of COVID-19 was adverse on the studied market owing to cancellations in elective procedures, including diagnosis and treatment of cardiovascular diseases, which impacted the studied market. For instance, according to an article published by the National Library of Medicine, in March 2022, there was a 52.7% reduction in adult cardiac surgery volume in the United States and a 65.5% reduction in elective cases. The Mid-Atlantic region was most affected by the COVID-19 surge in the initial phase, with a 69.7% reduction in overall case volume and an 80.0% reduction in elective cases. After the COVID-19 surge, nationwide cardiac surgical case volumes did not return to baseline, indicating a COVID-19-associated deficit of cardiac surgery patients. Hence, COVID-19 significantly impacted cardiac treatment and, consequently, the thermodilution catheter market. However, the current market is witnessing stabilized growth owing to the decrease in COVID-19 cases and is expected to project a similar trend over the coming years per the analysis.

The prevalence of cardiac diseases and increased incidences of stroke, as growing research and development activities to develop novel technologies in cardiac stroke management is actively affecting the growth of the studied market. For instance, according to the AHA's Heart Disease & Stroke Statistical Update Fact Sheet, published in January 2022, 244.1 million people were living with ischemic heart disease worldwide and it was more prevalent in males than in females (141.0 and 103.1 million people, respectively). Additionally, according to WHO data updated in June 2021, nearly 33.5 million people worldwide suffer from atrial fibrillation (AFib), the most common type of serious arrhythmia. The surge in cardiac diseases and incidences of stroke is projected to propel the demand for thermodilution catheters, required during the treatment of these diseases which is ultimately projected to boost the market growth.

The increasing product approvals, launches, partnerships, and acquisitions by key market players are projected to augment the market growth. For instance, in July 2022, the Zurich-based company Nanoflex Robotics, a spin-off from the Swiss Federal Institute of Technology in Zurich (ETH), developed an innovative catheter for rapid surgical interventions on stroke patients. Such developments are expected to boost the market growth.

While the market is poised for an upward trend, the lack of skilled healthcare professionals in emerging markets and difficulty in catheter localization in the patient's heart is likely to impede the market growth.

Thermodilution Catheter Market Trends

The Polyurethane Thermodilution Catheters is Expected to Witness Growth Over the Forecast Period

Polyurethane thermodilution catheters accounted for a significant share in recent years and are expected to do so over the forecast period owing to their wide range of applications, safety, reduced risk of patient latex allergy or hypersensitivity, and non-irritant nature. Additionally, an increased adoption rate of polyurethane catheters by doctors due to their enhanced mechanical strength and flexibility compared to silicon catheters is likely to drive the segment over the forecast period. For instance, an article published in NCBI in July 2022 stated that a Swan-Ganz catheter or right heart catheter is a quadruple-lumen catheter with a thermodilution sensor that is attached to a pressure transducer outside the body to identify the central vein pressure right atrial pressure, right ventricular pressure, and pulmonary artery pressure. These advantages and a rapid increase in the adoption of thermodilution catheters for monitoring pulmonary arterial pressure are also expected to increase the demand for manufacturers and propel the global market.

Moreover, rising company activities and product innovations are also expected to propel market growth over the forecast period. For instance, in March 2022, CATHI launched a new Right Heart Catheter simulator offering all the features of CATHI's original RHC simulator, with the additional benefits of wire-assisted navigation and the potential to work with real liquids (S-HUB), thereby allowing thermodilution to be performed.

Thermodilution Catheter Market - IMG1

North America is Expected to show a Significant Growth in the Thermodilution Catheter Market Over the Forecast Period.

North America is expected to show significant growth in the market owing to factors such as the rising incidence of cardiac diseases, growing geriatric population, better healthcare infrastructure, awareness among people and healthcare industry stakeholders about available technologies, and the strong presence of industry players in the region. For instance, according to a CDC 2022 update, 12.1 million people in the United States will likely have atrial fibrillation in 2030. As per the same source, one person dies every 34 seconds in the United States from cardiovascular disease. About 697,000 people in the United States died from heart disease in 2020, accounting for 1 in every 5 deaths. Owing to the high burden and severity of the disease, the utility of thermodilution catheters is expected to rise in the region.

Various campaigns are conducted in the region to protect lives impacted by heart diseases. For instance, the Centers for Medicare & Medicaid Services and the CDC in the United States jointly lead the nationwide Million Hearts campaign. The initiative commenced on January 2022 and will continue till December 2026. The goal of the initiative is to prevent 1 million heart attacks and strokes within 5 years. Such initiatives are likely to expedite the treatment and diagnosis of cardiac diseases to prevent strokes and other heart diseases and ultimately boost the usage of thermodilution catheters for monitoring cardiac output, which is projected to enhance the market in the region during the forecast period.

Thermodilution Catheter Market - IMG2

Thermodilution Catheter Industry Overview

The thermodilution catheters market is consolidated in nature due to the presence of a few companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. Some key market players are Alpha Medical Instruments LLC, Edwards Lifesciences, Teleflex Incorporated, DeRoyal Industries, ICU Medical Inc, Nolato AB, B. Braun SE, Merit Medical Systems Inc., Avicenna Healthcare Solutions, Advanced Lifesciences Pvt Ltd, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Global Prevalence of Cardiac Diseases and Increased Incidences of Stroke
    • 4.2.2 Growing R&D Activities to Develop Novel Technologies in Cardiac Stroke Management
  • 4.3 Market Restraints
    • 4.3.1 Difficulty in Catheter Localization in the Patient's Heart
    • 4.3.2 Lack of Skilled Healthcare Professionals in Emerging Markets
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Material
    • 5.1.1 Polyurethane
    • 5.1.2 Nylon
    • 5.1.3 Other Materials
  • 5.2 By End-User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Surgical Centers
    • 5.2.3 Other End-Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United states
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Alpha Medical Instruments LLC
    • 6.1.2 Teleflex Incorporated
    • 6.1.3 Edwards Lifesciences
    • 6.1.4 DeRoyal Industries
    • 6.1.5 ICU Medical Inc
    • 6.1.6 Nolato AB
    • 6.1.7 B. Braun SE
    • 6.1.8 Merit Medical Systems Inc
    • 6.1.9 Advanced Lifesciences Pvt Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS